OCT 25, 2016 12:34 PM PDT

New Compound in Onions Halts Ovarian Cancer Proliferation

WRITTEN BY: Xuan Pham
A study from the University of Japan finds that certain compounds in onions have anticancer effects against ovarian cancer. Onion lovers rejoice!
 
Known for its polarizing taste and pungent smell, onions are high in many vitamins and antioxidants. Studies have linked onions to health benefits, like strengthening the immune system, lowering blood pressure, and even fighting cancer.
 

One compound, aptly called onionin A (ONA), was recently identified by researchers at the Kumamoto University in Japan. ONA is high in sulfur and researchers believed it can squelch a tumor microenvironment. In particular, the team was especially interested in how ONA may act on epithelia ovarian cancer (EOC), which is often associated with tumor-associated macrophages.
 
In pre-clinical trials, the researchers treated EOC cells with the onion-derived compound. They found that ONA directly suppressed cancer cell proliferation. Furthermore, the effect appeared synergistic when combined with other anticancer drugs.
 
When the compound was used to treat a mouse model of EOC, the team found increased survival time. Molecular research also revealed that the signals for chemo-resistance was abolished with the application of ONA, suggesting a mechanism for how ONA acts on cancer cells.
 
The team concluded that “ONA is considered useful for the additional treatment of patients with ovarian cancer owing to its suppression of the pro-tumor activation of [tumor-associated macrophages] and direct cytotoxicity against cancer cells."
 

Of note, this first study to investigate the effect of an onion compound in ovarian cancer did not find any side effects in the animals. This, combined with the promising positive anticancer effects, could mean a faster path to human clinical trials and treatment.
 
Ovarian cancers have one of the highest mortality rates, ranking fifth in cancer deaths among women. Of the 22,000 new estimated cases of ovarian cancer this year, only 10-15 percent of patients will be successfully treated. Unfortunately, in the large percent of remaining patients, the cancer doesn’t respond to treatment, or will inevitably return with a vengeance. As such, research into low risk, natural compounds like ONA may be fruitful to fight this deadly disease.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 06, 2019
Health & Medicine
DEC 06, 2019
A Skin Patch Might be the Most Effective Melanoma Treatment
Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medicati...
DEC 06, 2019
Cardiology
DEC 06, 2019
Childhood Cancer Survivors Prone to Cardiac Events
A new study published in the American Heart Association's journal Circulation explores the relationship between childhood cancer, metabolic conditions ...
DEC 06, 2019
Cancer
DEC 06, 2019
It's not all bad: cancer and aging
Research published recently in the journal Aging Cell highlights the complexities of the interactions that occur during the aging process from the angle of...
DEC 06, 2019
Cancer
DEC 06, 2019
C2 combination targets cancer cells more efficiently
Treating cancer is in part so difficult because to be effective, high doses of aggressive drugs must be administered to patients. These treatments often ha...
DEC 06, 2019
Cancer
DEC 06, 2019
How flavonoids fight against colorectal cancer
New research published in the journal Cancers reports why flavonoids can aid in reducing the risk of colorectal cancer. Flavonoids are compounds found in f...
DEC 06, 2019
Cancer
DEC 06, 2019
Photon up-conversion for new cancer treatments
Scientists from the University of California, Riverside and The University of Texas at Austin have made a breakthrough in materials science that has signif...
Loading Comments...